Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$196,213
-$19,469 QoQ
Shares Held
1,252
-11.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,325
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hills Bank & Trust Co holds $20,137,806 across 12 Drug Manufacturers - General names. NVS ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
34,221 | $8,691,106 | |
| 2 | LLY |
ELI LILLY & Co
|
3,941 | $4,726,953 | |
| 3 | ABBV |
AbbVie Inc.
|
7,303 | $1,837,726 | |
| 4 | GSK |
GSK plc
|
17,496 | $917,140 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
15,545 | $895,702 | |
| 6 | MRK |
Merck & Co., Inc.
|
6,571 | $844,373 | |
| 7 | BIIB |
Biogen Inc.
|
3,088 | $667,193 | |
| 8 | PFE |
Pfizer Inc
|
24,108 | $580,519 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $196,213 | 1,252 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $215,682 | 1,412 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $194,671 | 1,412 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $181,074 | 1,412 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $170,865 | 1,412 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $157,409 | 1,412 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $141,196 | 1,451 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $156,426 | 1,360 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $154,366 | 1,450 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $140,354 | 1,451 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $147,718 | 1,463 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $149,020 | 1,463 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $144,300 | 1,430 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $151,708 | 1,649 | Shares | Defined | 2023-04-17 | |
| 2022-12-31 | $154,588 | 1,729 | Shares | Defined | 2023-02-06 | |
| 2022-09-30 | $139,782 | 1,839 | Shares | Defined | 2022-11-03 | |
| 2022-06-30 | $154,605 | 1,829 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $174,183 | 1,985 | Shares | Defined | 2022-08-16 | |
| 2021-12-31 | $195,319 | 2,233 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $238,551 | 2,917 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $266,693 | 2,923 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $257,123 | 3,008 | Shares | Defined | 2021-05-03 | |
| 2020-12-31 | $293,488 | 3,108 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $270,271 | 3,108 | Shares | Defined | 2020-10-27 | |
| 2020-06-30 | $293,287 | 3,358 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $270,518 | 3,281 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||